ARTICLE | Company News
FDA panel recommends Merck's antifungal
January 10, 2001 8:00 AM UTC
The FDA's Antiviral Advisory Committee unanimously recommended approval of MRK's Cancidas caspofungin, an inhibitor of beta 1,3-D-glucan in fungal cell walls, to treat invasive aspergillosis in patien...